FDA Inspection 1224841 — Noraxon USA, Inc.
The FDA completed an inspection of Noraxon USA, Inc. on Nov 30, 2023 in Scottsdale, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 30, 2023
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Scottsdale, AZ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3236 | 21 CFR 820.72(b) | Calibration procedures - content |